CYP1A1, GSTM1 and GSTT1 genetic polymorphism in Egyptian chronic myeloid leukemia patients

Research Journal of Immunology

Volumn 3, Issue 1, 2010, Pages 12-21

  Mahmoud, Shereen ^a   Labib, Dalia A ^a   Khalifa, Rania H ^a   Abu Khalil, Reham E ^a   Marie, Mohamed A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

CML; CYP1A1; GSTM1; GSTT1; Polymorphisms

Indexed keywords

CYTOCHROME P450 1A1; GENOMIC DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER SUSCEPTIBILITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EGYPT; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 77953396013     PISSN: 19947909     EISSN: None     Source Type: Journal    
DOI: 10.3923/rji.2010.12.21     Document Type: Article

References (33)

1. Abbas, A., K. Delvinquiere, M. Lechevrel, P. Lebailly, P. Gauduchon, G. Launoy and F. Sichel, 2004. GSTM1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to oesophageal cancer in a French population: Different pattern of squamous cell carcinoma and adenocarcinoma. World J. Gastroenterol., 10: 3389-3393.
2. Aktas, D., M. Hascicek, S. Sozen, H. Ozen and E. Tuncbilek, 2004. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet. Cytogenet., 154: 81-85.
3. Arruda, V.R., C.S. Lima, C.R. Grignoli, M.B. de Melo and B. Monica et al., 2001. Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur. J. Haematol., 66: 383-388.
4. Autrup, H., 2000. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res., 464: 65-76.
5. Bajpai, P., A.K. Tripathi and D. Agrawal, 2007. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res., 31: 1359-1363.
6. Bajpai, P., A.K. Tripathi and D. Agrawal, 2008. Genetic polymorphism of CYP1A1 and CYP2D6 in Indian chronic myeloid leukemia patients. Eur. J. Cancer suppl., 6: 101-106.
7. Björk, J., M. Albin, H. Welinder, H. Tinnerberg and N. Mauritzson et al., 2001. Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukemia? Occup. Environ. Med., 58: 722-727.
8. Canalle, R., R.V. Burim, L.G. Tone and C.S. Takahashi, 2004. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ. Mol. Mutagen., 43: 100-109.
9. Chan, E.C., S.Y. Lam, H.K. Fu and Y.L. Kwong, 2005. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1 and NQO1 genes in Chinese patients with non-small cell lung cancer: Relationship with aberrant promotor methylation of the CDKN2A and RARB genes. Cancer Genet. Cytogenet., 162: 10-20.
10. Chang, B.L., S.L. Zheng, S.D. Isaacs, A. Turner and G.A. Hawkins et al., 2003. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int. J. Cancer, 106: 375-378.
11. Chen, H.C., W.X. Hu, Q.X. Liu, W.K. Li and F.Z. Chen et al., 2008. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur. J. Cancer Prevent., 17: 251-258.
12. Deininger, W.N.M., J.M. Goldman and J.V. Melo, 2000. The molecular biology of chronic myeloid leukemia. Blood, 96: 3343-3356.
13. Dufour, C., J. Svahn, A. Bacigalupo, D. Longoni and S. Varotto et al., 2005. Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anaemia in Caucasian patients. Haematologica, 90: 1027-1031.
14. Gra, O.A., A.S. Glotov, E.A. Nikitin, O.S. Glotov and V.E. Kuznetsova et al., 2008. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-hodgkin lymphoma in adult Russian patients. Am. J. Hematol., 83: 279-287.
15. Guengerich, F., 1992. Metabolic activation of carcinogens. Pharmacol. Ther., 54: 17-61.
16. Hishida, A., S. Terakura, N. Emi, K. Yamamoto and M. Murata et al., 2005. GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac. J. Cancer Prevent., 6: 251-255.
17. Hung, R.J., P. Boffetta, J. Brockmöller, D. Butkiewicz and I. Cascorbi et al., 2003. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis, 24: 875-882.
18. Induski, J.A. and W. Lutz, 2000. Metabolic genotype in relation to individual susceptibility to environmental carcinogens. Int. Arch. Occup. Environ. Health, 73: 71-85.
19. Ingelman-Sundberg, M., 2001. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. Mutat. Res., 482: 11-19.
20. Krajinovic, M., D. Labuda, C. Richer, S. Karimi and D. Sinnett, 1999. Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1 and GSTT1 genetic polymorphisms. Blood, 93: 1496-1501.
21. Lourenco, G.J., M.M. Ortega, H. Nascimento, M.T. Teori, C.A. de Souza, F.E. Costa and C.S. Lima, 2005. Polymorphisms of glutathione-S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia. Eur. J. Haematol., 75: 530-531.
22. Lukas, A., M.D. Hefler, C.B. Tempfer, C. Grimm and A. Lebrecht et al., 2004. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian Women. Cancer, 101: 264-269.
23. Löffler, H., J. Bergmann, A. Hochhaus, R. Hehlmann and A. Kramer, 2001. Reduced risk for chronic myelogenous leukaemia in individuals with the cytochrome P-450 gene polymorphism CYP1A1*2A. Blood, 98: 3874-3879.
24. Medeiros, R., A. Vasconcelos, S. Costa, D. Pinto and P. Ferreira et al., 2004. Metabolic susceptibility genes and prostate cancer risk in a Southern European population: The role of glutathione Stransferases GSTM1, GSTM3 and GSTT1 genetic polymorphisms. Prostate, 58: 414-420.
25. Mondal, B.C., N. Paria, S. Majumdar, S. Chandra, A. Mukhopadhyay, U. Chaudhuri and U.B. Dasgupta, 2005. Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur. J. Cancer Prevent., 14: 281-284.
26. Nebert, D.W. and A.G. Menon, 2001. Pharmacogenomics, ethnicity and susceptibility genes. Pharmacogenom J., 1: 19-22.
27. Nebert, D.W., R.A. McKinnon and A. Puga, 1996. Human drug-metabolizing enzyme polymorphisms: Effect on risk of toxicity and cancer. DNA Cell Biol., 15: 273-280.
28. Olshan, A.F., M.C. Weissler, M.A. Watson and D.A. Bell, 2000. GSTM1,GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck Cancer. Cancer Epidemiol. Biomarkers Prevenmt., 9: 185-191.
29. Perera, F.P., 1996. Molecular epidemiology: Insights into cancer susceptibility, risk assessment, and prevention. J. Natl. Cancer Inst., 88: 496-509.
30. Rollinson, S., P. Roddam, E. Kane, R. Eve and C. Ray et al., 2000. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis, 21: 43-47.
31. Sim, S.C. and M. Ingelman-Sundberg, 2006. The human cytochrome P450 allele nomenclature committee web site: Submission criteria, procedures, and objectives. Methods Mol. Biol., 320: 183-191.
32. Taspinar, M., S.E. Aydos, O. Comez, A.H. Elhan, H.G. Karabulut and A. Sunguroglu, 2008. CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukemia. Swiss Med. Weekly, 138: 12-17.
33. Terry, K.L., L. Titus-Ernstoff, E.O. Garner, A.F. Vitonis and D.W. Cramer, 2003. Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk. Cancer Epidemiol. Biomarkers Prevevt., 12: 187-190.